Top 5 Dos and Don’ts for Safe Prescribing for Trans and Non-binary Individuals
)
Ensuring safe and inclusive prescribing for transgender and non-binary individuals can be challenging for clinicians to get right, primarily due to limited guidance on communication, drug interactions, and referrals.
To bridge this gap, OUTpatients, the UK’s LGBTQI+ cancer charity, and the British Oncology Pharmacy Association (BOPA) developed the TRANScribing document – a free online resource offering guidance on how to conduct an inclusive consultation and explores the pharmacological considerations that all pharmacy professionals and prescribers should be aware of.
In an exclusive discussion with the Pharmacy Show, the team shared key lessons from their work, offering five essential dos and don’ts for safe prescribing. Their insights extend beyond oncology, providing valuable guidance for all pharmacy professionals seeking to improve care for transgender and non-binary patients.
The Pharmacy Show 2025, taking place October 12-13th at Birmingham NEC, where OUTpatients will present detailed guidance on this crucial topic.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
.png/fit-in/500x500/filters:no_upscale())
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
)
.png/fit-in/1280x9999/filters:no_upscale()){kind=logo}
)
)
)
)
)
)
){kind=logo}
